cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Recursion Pharmaceuticals A
3 own
2 watching
Current Price
$8.54
$0.35
(4.27%)
logo-rxrx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,486.58M
52-Week High
52-Week High
14.18
52-Week Low
52-Week Low
4.92
Average Volume
Average Volume
0.73M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,486.58M
icon52-Week High14.18
icon52-Week Low4.92
iconAverage Volume0.73M
iconDividend Yield--
iconP/E Ratio--
What does the Recursion Pharmaceuticals A do?
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; REC-65029 to treat HRD-negative ovarian cancer; REC-648918 to enhance anti-tumor immune; REC-2029 for the treatment of wnt-mutant hepatocellular carcinoma; REC-14221 to treat solid and hematological malignancies; and REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Read More
How much money does Recursion Pharmaceuticals A make?
News & Events about Recursion Pharmaceuticals A.
PR Newswire
1month ago
Recursion to Participate in Upcoming Investor Conferences Recursion to Participate in Upcoming Investor Conferences PR Newswire SALT LAKE CITY, Dec. 20, 2022 SALT LAKE CITY, Dec. 20, 2022 /PRNewswire/ --Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug...
Zolmax
4 months ago
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX Get Rating) insider Shafique Virani sold 10,000 shares of the businesss stock in a transaction that occurred on Thursday, September 15th. The shares were sold at an average price of $13.36, for a total value of $133,600.00. Following the ...
Zolmax
5 months ago
Exscientia (NASDAQ:EXAI Get Rating) and Recursion Pharmaceuticals (NASDAQ:RXRX Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ...
PR Newswire
7 months ago
Recursion Announces Initiation of Phase 2/3 Trial for the Treatment of NF2-Mutated Meningiomas at Children's Tumor Foundation NF Conference Recursion Announces Initiation of Phase 2/3 Trial for the Treatment of NF2-Mutated Meningiomas at Children's Tumor Foundation NF Conference PR Newswire SALT...
Zolmax
7 months ago
Bank of America Corp DE grew its position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX Get Rating) by 545.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 171,175 shares of the companys stock after acquiring...
Frequently Asked Questions
Frequently Asked Questions
What is Recursion Pharmaceuticals A share price today?
plus_minus_icon
Can Indians buy Recursion Pharmaceuticals A shares?
plus_minus_icon
How can I buy Recursion Pharmaceuticals A shares from India?
plus_minus_icon
Can Fractional shares of Recursion Pharmaceuticals A be purchased?
plus_minus_icon
What are the documents required to start investing in Recursion Pharmaceuticals A stocks?
plus_minus_icon
What is today’s traded volume of Recursion Pharmaceuticals A?
plus_minus_icon
What is today’s market capitalisation of Recursion Pharmaceuticals A?
plus_minus_icon
What is the 52-Week High and Low Range of Recursion Pharmaceuticals A?
plus_minus_icon
What percentage is Recursion Pharmaceuticals A down from its 52-Week High?
plus_minus_icon
What percentage is Recursion Pharmaceuticals A up from its 52-Week Low?
plus_minus_icon
Current Price
$8.54
$0.35
(4.27%)
logo-rxrx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00